Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion type Assertion NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_head.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion description "[This result is consistent with a protective effect of DRB1*04 that may allow individuals to tolerate higher levels of hyperglycemia, as measured by A1C, without developing nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_provenance.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion evidence source_evidence_literature NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_provenance.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion SIO_000772 18039812 NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_provenance.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion wasDerivedFrom befree-20140225 NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_provenance.
- NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_assertion wasGeneratedBy ECO_0000203 NP616536.RAVOAWg15th3lxgw6d6qQnSN2K8lO5PSoD1rsIE1skSZ4130_provenance.